The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

Miquel Martin

Laboratori de Neurofarmacologia, Facultat de Ciencies de la Salut i de la Vida, Universitat Pompeu Fabra, c/Doctor Aiguader 80, 08003 Barcelona, Spain

Search for more papers by this author
Catherine Ledent

IRIBHN, Université libre de Bruxelles, B‐1070 Brussels, Belgium

Search for more papers by this author
Marc Parmentier

IRIBHN, Université libre de Bruxelles, B‐1070 Brussels, Belgium

Search for more papers by this author
Rafael Maldonado

Laboratori de Neurofarmacologia, Facultat de Ciencies de la Salut i de la Vida, Universitat Pompeu Fabra, c/Doctor Aiguader 80, 08003 Barcelona, Spain

Search for more papers by this author
Olga Valverde

Laboratori de Neurofarmacologia, Facultat de Ciencies de la Salut i de la Vida, Universitat Pompeu Fabra, c/Doctor Aiguader 80, 08003 Barcelona, Spain

Search for more papers by this author
First published: 09 October 2008
Cited by: 136
: Dr Olga Valverde, as above.
E‐mail: [email protected]

Abstract

The involvement of cannabinoid CB1 receptors in morphine and cocaine motivational effects was investigated using CB1 knockout mice. For this purpose, we evaluated the rewarding effects in the place conditioning paradigm and the sensitization to the locomotor responses induced by these drugs. The hyperlocomotion induced by acute morphine administration (15 mg/kg, s.c.) was preserved, but the sensitization to this locomotor response induced by chronic morphine treatment was abolished in CB1 mutant mice. Morphine (5 mg/kg, s.c.) induced conditioned place preference in wild‐type mice but failed to produce any response in knockout mice, indicating the inability of morphine to induce rewarding effects in the absence of CB1 cannabinoid receptors. When the aversive effects of morphine withdrawal were investigated using the place aversion paradigm, no differences between genotypes were observed. Acute cocaine (10 mg/kg, i.p.) induced hyperlocomotor responses in wild‐type and knockout mice and a chronic cocaine treatment produced a similar sensitization to this response in both genotypes. In the conditioning place preference paradigm, cocaine (20 mg/kg, i.p.) produced rewarding responses in both wild‐type and knockout mice. These results demonstrate that CB1 receptors are essential for adaptive responses produced by chronic morphine but not by chronic cocaine treatment.

Number of times cited: 136

  • , Plasma Cocaine Metabolite Levels and Liver CYP450 3A4 Isoenzyme Activity as Indicators of Cocaine Metabolism in Rats Treated With Salako Supplements, Strategic Applications of Measurement Technologies and Instrumentation, 10.4018/978-1-5225-5406-6.ch001, (1-21)
  • , Influence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain, Neuropharmacology, 10.1016/j.neuropharm.2019.01.012, (2019).
  • , Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling, Neuropsychopharmacology, 43, 1, (103), (2018).
  • , Loren Parsons' contribution to addiction neurobiology, Addiction Biology, 23, 6, (1207-1222), (2018).
  • , Role of the endocannabinoid system in drug addiction, Biochemical Pharmacology, 10.1016/j.bcp.2018.09.013, (2018).
  • , Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology, Endocannabinoids and Lipid Mediators in Brain Functions, 10.1007/978-3-319-57371-7_10, (257-318), (2017).
  • , Mice expressing a “hyper-sensitive” form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption, PLOS ONE, 12, 4, (e0174826), (2017).
  • , Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine, Behavioural Pharmacology, 28, 7, (493), (2017).
  • , Binge ethanol drinking during adolescence modifies cocaine responses in mice, Journal of Psychopharmacology, 31, 1, (86), (2017).
  • , The Role of the Endocannabinoid System in Addiction, The Endocannabinoid System, 10.1016/B978-0-12-809666-6.00006-X, (187-236), (2017).
  • , Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes, Physiology & Behavior, 170, (141), (2017).
  • , Class A GPCRs: Cannabinoid and Opioid Receptor Heteromers, G-Protein-Coupled Receptor Dimers, 10.1007/978-3-319-60174-8_7, (173-206), (2017).
  • , Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons, Nature Communications, 7, (12199), (2016).
  • , CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens, Journal of Molecular Neuroscience, 58, 4, (446), (2016).
  • , Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus, European Neuropsychopharmacology, 26, 3, (477), (2016).
  • , Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors, Neuropsychopharmacology, 41, 9, (2192), (2016).
  • , Morphine‐induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1‐R activity, Addiction Biology, 21, 6, (1113-1126), (2015).
  • , The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL‐α expression following short‐term morphine withdrawal, British Journal of Pharmacology, 173, 7, (1143-1153), (2014).
  • , Maternal Separation Impairs Cocaine-Induced Behavioural Sensitization in Adolescent Mice, PLOS ONE, 11, 12, (e0167483), (2016).
  • , Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats, International Journal of Neuropsychopharmacology, (pyw102), (2016).
  • , Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature, Frontiers in Pharmacology, 7, (2016).
  • , Medial prefrontal cannabinoid CB1 receptors modulate consolidation and extinction of cocaine-associated memory in mice, Psychopharmacology, 232, 10, (1803), (2015).
  • , Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies, Frontiers in Pharmacology, 6, (2015).
  • , Inhibition of Histone Deacetylase in the Basolateral Amygdala Facilitates Morphine Context-Associated Memory Formation in Rats, Journal of Molecular Neuroscience, 55, 1, (269), (2015).
  • , Memory Impairment and Reduced Exploratory Behavior in Mice after Administration of Systemic Morphine, Journal of Experimental Neuroscience, 9, (JEN.S25057), (2015).
  • , Changes in mu-opioid receptor expression and function in the mesolimbic system after long-term access to a palatable diet, Pharmacology & Therapeutics, 154, (110), (2015).
  • , Functional interaction between the orexin-1 and CB1 receptors within the nucleus accumbens in the conditioned place preference induced by the lateral hypothalamus stimulation, Pharmacology Biochemistry and Behavior, 132, (42), (2015).
  • , Plasma Cocaine Metabolite and Liver CYP450 3A4 Isoenzyme Levels as Indicators of Cocaine Dependence in Rats Treated with Nutritional Supplements, International Journal of Measurement Technologies and Instrumentation Engineering, 10.4018/IJMTIE.2015070103, 5, 2, (28-43), (2015).
  • , Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine, Behavioural Brain Research, 270, (261), (2014).
  • , Cannabinoid receptors in the basolateral amygdala are involved in the potentiation of morphine rewarding properties in the acquisition, but not expression of conditioned place preference in rats, Brain Research, 1565, (28), (2014).
  • , Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats, Psychopharmacology, 231, 7, (1417), (2014).
  • , NeuroHIV and Use of Addictive Substances, Neuroimmune Signaling in Drug Actions and Addictions, 10.1016/B978-0-12-801284-0.00013-0, (403-440), (2014).
  • , FAAH selectively influences placebo effects, Molecular Psychiatry, 19, 3, (385), (2014).
  • , Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model, Behavioural Brain Research, 247, (259), (2013).
  • , Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction, Pharmacology & Therapeutics, 138, 1, (84), (2013).
  • , CNR1 gene deletion affects the density of endomorphin-2 binding sites in the mouse brain in a hemisphere-specific manner, European Journal of Pharmacology, 698, 1-3, (220), (2013).
  • , Influence of pre-exposure to morphine on cannabinoid-induced impairment of spatial memory in male rats, Behavioural Brain Research, 256, (157), (2013).
  • , The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice, Psychopharmacology, 229, 4, (591), (2013).
  • , Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference, Behavioural Brain Research, 247, (125), (2013).
  • , Endocannabinoid system and drug addiction: new insights from mutant mice approaches, Current Opinion in Neurobiology, 23, 4, (480), (2013).
  • , Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: Role of CB1 receptors, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 47, (77), (2013).
  • , The orphan receptor GPR3 modulates the early phases of cocaine reinforcement, British Journal of Pharmacology, 167, 4, (892-904), (2012).
  • , AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies, Neuropharmacology, 63, 5, (905), (2012).
  • , Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring, Journal of Psychopharmacology, 26, 10, (1348), (2012).
  • , Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors, Neuropsychopharmacology, 37, 7, (1749), (2012).
  • , Cocaine withdrawal reduces group I mGluR‐mediated long‐term potentiation via decreased GABAergic transmission in the amygdala, European Journal of Neuroscience, 34, 2, (177-189), (2011).
  • , Differential effect of opioid and cannabinoid receptor blockade on heroin‐seeking reinstatement and cannabinoid substitution in heroin‐abstinent rats, British Journal of Pharmacology, 163, 7, (1550-1562), (2011).
  • , Zebrafish models to study drug abuse-related phenotypes, Reviews in the Neurosciences, 22, 1, (2011).
  • , Cannabinoids: Neurochemistry and neurobiology, Biology Bulletin Reviews, 1, 6, (526), (2011).
  • , Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2011.06.005, 132, 3, (215-241), (2011).
  • , Effects of cannabinoid CB1 receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice, Behavioural Brain Research, 217, 1, (111), (2011).
  • , Functional Neuroimaging of the Acute Effects of Drugs of Abuse, Neuroimaging in Addiction, (83-104), (2011).
  • , Endocannabinoid-mediated synaptic plasticity and addiction-related behavior, Neuropharmacology, 10.1016/j.neuropharm.2011.05.034, 61, 7, (1070-1087), (2011).
  • , Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference, Neuroscience Letters, 468, 3, (186), (2010).
  • , Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum, Neuropsychopharmacology, 35, 2, (374), (2010).
  • , PRECLINICAL STUDY: FULL ARTICLE: Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR‐α nuclear receptors, Addiction Biology, 15, 3, (277-288), (2010).
  • , Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors, Neuroscience, 167, 2, (205), (2010).
  • , Central antinociception induced by µ‐opioid receptor agonist morphine, but not δ‐ or κ‐, is mediated by cannabinoid CB1 receptor, British Journal of Pharmacology, 158, 1, (225-231), (2009).
  • , Interaction of the cannabinoid and opioid systems in the modulation of nociception, International Review of Psychiatry, 21, 2, (143), (2009).
  • , Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure, Life Sciences, 85, 5-6, (248), (2009).
  • , Sub-chronic administration of AM251, CB1 receptor antagonist, within the nucleus accumbens induced sensitization to morphine in the rat, Neuroscience Letters, 467, 1, (43), (2009).
  • , Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats, Behavioural Brain Research, 202, 2, (260), (2009).
  • , Neural Basis of Pleasure and Reward, Handbook of Neuroscience for the Behavioral Sciences, (2009).
  • , Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice, Psychopharmacology, 204, 1, (1), (2009).
  • , The role of CB1 receptors in psychostimulant addiction, Addiction Biology, 13, 2, (225-238), (2008).
  • , A neuropeptide‐centric view of psychostimulant addiction, British Journal of Pharmacology, 154, 2, (343-357), (2009).
  • , The endocannabinoid system in brain reward processes, British Journal of Pharmacology, 154, 2, (369-383), (2009).
  • , Anandamide effects on 5-HT3 receptors in vivo, European Journal of Pharmacology, 596, 1-3, (98), (2008).
  • , Candidate gene polymorphisms predicting individual sensitivity to opioids, Naunyn-Schmiedeberg's Archives of Pharmacology, 377, 4-6, (269), (2008).
  • , Effects of cocaine in 5-lipoxygenase-deficient mice, Journal of Neural Transmission, 115, 3, (389), (2008).
  • , Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice, Behavioural Pharmacology, 19, 5-6, (575), (2008).
  • , Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine, The International Journal of Neuropsychopharmacology, 11, 07, (2008).
  • , Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase, European Journal of Pharmacology, 600, 1-3, (50), (2008).
  • , CB1Cannabinoid Receptor Modulates 3,4-Methylenedioxymethamphetamine Acute Responses and Reinforcement, Biological Psychiatry, 63, 11, (1030), (2008).
  • , Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors, Neurochemistry International, 52, 1-2, (321), (2008).
  • , Augmented Acquisition of Cocaine Self-Administration and Altered Brain Glucose Metabolism in Adult Female but not Male Rats Exposed to a Cannabinoid Agonist during Adolescence, Neuropsychopharmacology, 33, 4, (806), (2008).
  • , Context-Specific Reversal of Cocaine Sensitization by the CB1 Cannabinoid Receptor Antagonist Rimonabant, Neuropsychopharmacology, 33, 11, (2747), (2008).
  • , Behavioral sensitization to Δ9‐tetrahydrocannabinol and cross‐sensitization with morphine: differential changes in accumbal shell and core dopamine transmission, Journal of Neurochemistry, 106, 4, (1586-1593), (2008).
  • , Elevation of pentylenetetrazole‐induced seizure threshold in cholestatic mice: Interaction between opioid and cannabinoid systems, Journal of Gastroenterology and Hepatology, 23, 7pt2, (e251-e257), (2007).
  • , Advances in the field of cannabinoid–opioid cross‐talk, Addiction Biology, 13, 2, (213-224), (2008).
  • , Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210, European Journal of Pharmacology, 586, 1-3, (197), (2008).
  • , Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex, Psychopharmacology, 10.1007/s00213-008-1141-8, 198, 4, (497-508), (2008).
  • , Cannabinoid CB1 Receptor Antagonists Attenuate Cocaine's Rewarding Effects: Experiments with Self-Administration and Brain-Stimulation Reward in Rats, Neuropsychopharmacology, 33, 7, (1735), (2008).
  • , A reliable method to study cue-, priming-, and stress-induced reinstatement of cocaine self-administration in mice, Psychopharmacology, 199, 4, (593), (2008).
  • , REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addiction Biology, 12, 3‐4, (227-462), (2007).
  • , Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors, European Journal of Neuroscience, 25, 6, (1631-1640), (2007).
  • , Pharmacology and Treatments, Drugs and the Future, 10.1016/B978-012370624-9/50009-8, (169-208), (2007).
  • , Blocking the Cannabinoid Receptors: Drug Candidates and Therapeutic Promises, Chemistry & Biodiversity, 4, 8, (1805-1827), (2007).
  • , The anandamide transport inhibitor AM404 reduces ethanol self‐administration, European Journal of Neuroscience, 26, 2, (476-486), (2007).
  • , The role of the cannabinoid type 1 receptor and down‐stream cAMP/DARPP‐32 signal in the nucleus accumbens of methamphetamine‐sensitized rats, Journal of Neurochemistry, 103, 6, (2505-2517), (2007).
  • , Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through a CB1 cannabinoid receptor–dependent mechanism, Neuroscience, 146, 4, (1536), (2007).
  • , An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives, Brain Research Reviews, 53, 1, (1), (2007).
  • , Previous Exposure to THC Alters the Reinforcing Efficacy and Anxiety-Related Effects of Cocaine in Rats, Neuropsychopharmacology, 32, 3, (646), (2007).
  • , Subchronic Cannabinoid Agonist (WIN 55,212-2) Treatment during Cocaine Abstinence Alters Subsequent Cocaine Seeking Behavior, Neuropsychopharmacology, 10.1038/sj.npp.1301365, 32, 11, (2260-2266), (2007).
  • , The neurochemistry of the psychological dependence syndrome in addictive diseases of chemical etiology, Neurochemical Journal, 10.1134/S1819712407010011, 1, 1, (1-13), (2007).
  • , Adenosine A2a blockade prevents synergy between  -opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats, Proceedings of the National Academy of Sciences, 103, 20, (7877), (2006).
  • , Chronic treatment with Δ-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats, Synapse, 60, 6, (429), (2006).
  • , Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway, Neuropsychopharmacology, 31, 4, (804), (2006).
  • , A potential novel strategy to separate therapeutic‐ and side‐effects that are mediated via the same receptor: β‐arrestin2/G‐protein coupling antagonists, Journal of Clinical Pharmacy and Therapeutics, 31, 2, (119-128), (2006).
  • , Psychosis pathways converge via D2High dopamine receptors, Synapse, 60, 4, (319-346), (2006).
  • , Involvement of the endocannabinoid system in drug addiction, Trends in Neurosciences, 29, 4, (225), (2006).
  • , Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats, Psychopharmacology, 10.1007/s00213-006-0525-x, 189, 1, (59-69), (2006).
  • , Cannabinoid Agonists but not Inhibitors of Endogenous Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin in Rats, Neuropsychopharmacology, 30, 11, (2046), (2005).
  • , Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization, European Neuropsychopharmacology, 15, 1, (31), (2005).
  • , Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction, Neuropharmacology, 48, 8, (1105), (2005).
  • , Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems, Neuropsychopharmacology, 30, 11, (2035), (2005).
  • , Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors, Behavioural Brain Research, 164, 2, (206), (2005).
  • , Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats, Psychopharmacology, 181, 4, (722), (2005).
  • , CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors, Neuropsychopharmacology, 30, 2, (339), (2005).
  • , Behavioral Effects of Endocannabinoids, Endocannabinoids, 10.1201/9781420023640.ch13, (2010).
  • , CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited, Brain Research, 1063, 1, (77), (2005).
  • , Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration, Neuropsychopharmacology, 30, 9, (1670), (2005).
  • , DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine, European Journal of Neuroscience, 19, 11, (3033-3041), (2004).
  • , Addictive and non‐addictive drugs induce distinct and specific patterns of ERK activation in mouse brain, European Journal of Neuroscience, 19, 7, (1826-1836), (2004).
  • , A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission, Neuropsychopharmacology, 29, 8, (1488), (2004).
  • , A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine, Brain Research, 1026, 2, (244), (2004).
  • , Mu opioid receptor: a gateway to drug addiction, Current Opinion in Neurobiology, 14, 3, (370), (2004).
  • , Reduced sensitivity to reward in CB1 knockout mice, Psychopharmacology, 10.1007/s00213-004-1877-8, 176, 2, (223-232), (2004).
  • , SR141716A reduces the reinforcing properties of heroin but not heroin‐induced increases in nucleus accumbens dopamine in rats, European Journal of Neuroscience, 18, 11, (3145-3149), (2003).
  • , Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice, European Journal of Neuroscience, 17, 1, (155-159), (2002).
  • , The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders, European Journal of Pharmacology, 10.1016/j.ejphar.2003.08.101, 480, 1-3, (133-150), (2003).
  • , Cannabis and alcohol – a close friendship, Trends in Pharmacological Sciences, 24, 6, (266), (2003).
  • , Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice, Behavioural Pharmacology, 14, 3, (237), (2003).
  • , Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats, European Journal of Pharmacology, 465, 1-2, (105), (2003).
  • , Neurobiology of addiction and implications for treatment, British Journal of Psychiatry, 182, 02, (97), (2003).
  • , Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine, British Journal of Pharmacology, 135, 2, (564-578), (2009).
  • , Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence, Neuropharmacology, 43, 5, (857), (2002).
  • , Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1, Biological Psychiatry, 51, 8, (612), (2002).
  • , Conditioned place preference to morphine in cannabinoid CB1 receptor knockout mice, Brain Research, 945, 1, (135), (2002).
  • , Molecular biology of cannabinoid receptors, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 66, 2-3, (123), (2002).
  • , Knockout of ERK1 MAP Kinase Enhances Synaptic Plasticity in the Striatum and Facilitates Striatal-Mediated Learning and Memory, Neuron, 34, 5, (807), (2002).
  • , Study of cannabinoid dependence in animals, Pharmacology & Therapeutics, 95, 2, (153), (2002).
  • , Addiction and Genes: Animal Models, eLS, (2006).
  • , Endogenous opiates: 2000, Peptides, 10.1016/S0196-9781(01)00566-6, 22, 12, (2257-2328), (2001).
  • , Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression, Frontiers in Molecular Neuroscience, 10.3389/fnmol.2018.00424, 11, (2018).
  • , CB1 Agonism Alters Addiction-Related Behaviors in Mice Lacking Mu or Delta Opioid Receptors, Frontiers in Psychiatry, 10.3389/fpsyt.2018.00630, 9, (2018).